The elevated expression of IL-17A in antigen-restricted CD4+ T cells primed by PDATME DC paralleled the phenotype of CD4+ T cells in situ in PDA, which expressed greater IL-17A than splenic CD4+ T cells in PDA-bearing mice (Supplementary Figure 1I). This evidence concerns the gene IL17A and Patent ductus arteriosus.